Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.5501
+0.0161 (3.01%)
At close: Jul 11, 2025, 4:00 PM
0.5000
-0.0501 (-9.11%)
After-hours: Jul 11, 2025, 7:58 PM EDT

Moleculin Biotech Statistics

Total Valuation

MBRX has a market cap or net worth of $13.26 million. The enterprise value is $5.99 million.

Market Cap 13.26M
Enterprise Value 5.99M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, before market open.

Earnings Date Aug 13, 2025
Ex-Dividend Date n/a

Share Statistics

MBRX has 24.10 million shares outstanding. The number of shares has increased by 144.32% in one year.

Current Share Class 24.10M
Shares Outstanding 24.10M
Shares Change (YoY) +144.32%
Shares Change (QoQ) +85.41%
Owned by Insiders (%) 4.33%
Owned by Institutions (%) 0.95%
Float 21.80M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 185.09
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 10.71.

Current Ratio 1.35
Quick Ratio 1.12
Debt / Equity 10.71
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -214.79% and return on invested capital (ROIC) is -143.05%.

Return on Equity (ROE) -214.79%
Return on Assets (ROA) -62.45%
Return on Invested Capital (ROIC) -143.05%
Return on Capital Employed (ROCE) -183.52%
Revenue Per Employee n/a
Profits Per Employee -$1.37M
Employee Count 17
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -83.77% in the last 52 weeks. The beta is 1.38, so MBRX's price volatility has been higher than the market average.

Beta (5Y) 1.38
52-Week Price Change -83.77%
50-Day Moving Average 0.73
200-Day Moving Average 1.53
Relative Strength Index (RSI) 51.51
Average Volume (20 Days) 11,778,729

Short Selling Information

The latest short interest is 3.44 million, so 14.29% of the outstanding shares have been sold short.

Short Interest 3.44M
Short Previous Month 1.93M
Short % of Shares Out 14.29%
Short % of Float 15.79%
Short Ratio (days to cover) 2.21

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -25.91M
Pretax Income -26.82M
Net Income -23.23M
EBITDA -25.78M
EBIT -25.91M
Earnings Per Share (EPS) -$4.50
Full Income Statement

Balance Sheet

The company has $7.72 million in cash and $450,000 in debt, giving a net cash position of $7.27 million or $0.30 per share.

Cash & Cash Equivalents 7.72M
Total Debt 450,000
Net Cash 7.27M
Net Cash Per Share $0.30
Equity (Book Value) 42,000
Book Value Per Share 0.00
Working Capital 2.44M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.71 million and capital expenditures -$13,000, giving a free cash flow of -$21.72 million.

Operating Cash Flow -21.71M
Capital Expenditures -13,000
Free Cash Flow -21.72M
FCF Per Share -$0.90
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MBRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -144.32%
Shareholder Yield -144.32%
Earnings Yield -175.22%
FCF Yield -163.85%

Analyst Forecast

The average price target for MBRX is $5.33, which is 868.92% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.33
Price Target Difference 868.92%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on March 22, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date Mar 22, 2024
Split Type Reverse
Split Ratio 0.0666667:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1